 Despite a struggling IPO market in 2022, Harmony Biosciences and ProFrac are holding up well in the ongoing stock market correction. The post IPO Stock Leaders Harmony, ProFrac Outperform Despite Tough 2022 Market appeared first on Investors Business Daily. 